Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 5/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propionic Acid SCHEMBL508029 | 0.88 | MEN1 (0.33) | MEN1HSP90AA1KMT2ASMN1; SMN2FDPS | |
| Heptanoate SCHEMBL1661522 | 0.88 | FABP3 (0.45) | CA1MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Dodecanoate SCHEMBL1661287 | 0.88 | FABP3 (0.45) | CA1MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Stearic Acid SCHEMBL22362218 | 0.88 | FABP3 (0.45) | CA1MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Octanoic Acid SCHEMBL1661278 | 0.88 | FABP3 (0.45) | CA1MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Undecanoate SCHEMBL1663984 | 0.88 | FABP3 (0.45) | CA1MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Nonanoate SCHEMBL1661376 | 0.88 | FABP3 (0.45) | CA1MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Decanoic Acid SCHEMBL1662199 | 0.88 | FABP3 (0.45) | CA1MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Bicarbonate SCHEMBL2936301 | 0.88 | MEN1 (0.35) | MEN1HSP90AA1KMT2ASMN1; SMN2FDPS | |
| Succinic Acid SCHEMBL28948454 | 0.87 | FFAR3 (0.31) | FFAR3HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120095207-A1 | CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2012-04-19 | — | — | US | claimed |
| US-8153782-B2 | Cellulose esterification; ion exchanging; acylation; slurrying | EASTMAN CHEMICAL COMPANY (US) | 2012-04-10 | — | — | US | claimed |
| US-8148518-B2 | Cellulose esterification; ion exchanging; acylation; slurrying | EASTMAN CHEMICAL COMPANY (US) | 2012-04-03 | — | — | US | claimed |
| US-7919631-B2 | Production of ionic liquids | EASTMAN CHEMICAL COMPANY (US) | 2011-04-05 | — | — | US | claimed |
| EP-2121766-A1 | CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS | Eastman Chemical Company (US) | 2009-11-25 | — | — | EP | claimed |
| EP-2118070-A1 | PRODUCTION OF IONIC LIQUIDS | Eastman Chemical Company (US) | 2009-11-18 | — | — | EP | claimed |
| EP-2118143-A1 | REFORMATION OF IONIC LIQUIDS | Eastman Chemical Company (US) | 2009-11-18 | — | — | EP | claimed |
| WO-2008100569-A1 | REFORMATION OF IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-21 | — | — | WO | claimed |
| WO-2008100577-A1 | PRODUCTION OF IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-21 | — | — | WO | claimed |
| WO-2008100566-A1 | CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-21 | — | — | WO | claimed |
| US-20080194834-A1 | PRODUCTION OF IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-14 | — | — | US | claimed |
| US-20080194808-A1 | CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-14 | — | — | US | claimed |
| US-20080194807-A1 | REFORMATION OF IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-14 | — | — | US | claimed |
| EP-3239179-B1 | REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS PRODUCED IN A CARBOXYLATED IONIC LIQUID PROCESS AND PRODUCTS PRODUCED THEREFROM | EASTMAN CHEM CO (US) | 2023-02-22 | — | — | EP | disclosed |
| CN-103923352-B | Regioselectively substituted cellulose esters prepared by carboxylated ionic liquid processes and products prepared therefrom | 伊士曼化工公司 | 2020-10-16 | — | — | CN | disclosed |
| CN-110066345-B | Preparation method of polysaccharide ester | 中国科学院化学研究所 | 2020-07-14 | — | — | CN | disclosed |
| WO-2008100569-A1 | REFORMATION OF IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-21 | — | — | WO | disclosed |
| US-20080194834-A1 | PRODUCTION OF IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-14 | — | — | US | disclosed |
| US-20080194808-A1 | CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-14 | — | — | US | disclosed |
| US-20080194807-A1 | REFORMATION OF IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194834-A1 | PRODUCTION OF IONIC LIQUIDS | GLUL, ICMT, ALAD | FFAR3 3797/4885HDAC3 3816/4885HDAC1 3780/4885 |
| US-20080194808-A1 | CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS | CEL, ACMSD, ACOT7 | FFAR3 787/4885HDAC3 299/4885HDAC1 533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.